Article info
Heart failure
Original article
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
- Correspondence to Professor Martin R Cowie, Imperial College London, Dovehouse Street, London SW3 6LY, UK; m.cowie{at}imperial.ac.uk
Citation
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
Publication history
- Received July 12, 2013
- Revised December 16, 2013
- Accepted February 9, 2014
- First published March 14, 2014.
Online issue publication
January 29, 2024
Article Versions
- Previous version (29 January 2024).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/